Brief: FibroBiologics Issued Patent For Fibroblast Delivery Of Tumor Inhibitory Agents By The European Patent Office
16/10/2024 14:22
Oct 16 (Reuters) - Fibrobiologics Inc FBLG.O :
* FIBROBIOLOGICS ISSUED PATENT FOR FIBROBLAST DELIVERY OF
TUMOR
INHIBITORY AGENTS BY THE EUROPEAN PATENT OFFICE
Source text for Eikon: ID:nGNX5kPjWh
Further company coverage: FBLG.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Fibrobiologics
See all newsBrief: Fibrobiologics Files Patent Application For Technology Designed To Produce Glp-1 And Other Therapeutic Peptides Inside The Body
Brief: Fibrobiologics Announces Chondrocyte Spheroids Demonstrate Cartilage Repair In Preclinical Study Of Degenerative Joints
U.S. STOCKS ON THE MOVEX-Abbott, Columbia Financial, Jabil
U.S. STOCKS ON THE MOVEX-Abbott, Columbia Financial, Jabil,
Brief: Fibrobiologics Granted US Patent Covering The Use Of Fibroblasts